ALB vs AXGN · rev $1.74B vs rev $131.2M
Albemarle Corp (ALB) versus Axogen Inc (AXGN) — a side-by-side from cached financials, not a winner call.
Albemarle Corp (ALB) is a specialty chemicals company listed on US.
Axogen Inc (AXGN) is a medical devices company listed on US.
Latest reported ALB revenue for 2026-06-30 was $1.74B. Net income was $480.0M. Revenue was up 22.0% from 2026-03-31 to 2026-06-30. ALB currently screens at market cap $8.00B.
Latest reported AXGN revenue for 2026-06-30 was $131.2M. Net income was -$21.1M. AXGN currently screens at market cap $497.8M.
ALB currently screens at market cap $8.00B. AXGN currently screens at market cap $497.8M.
Not investment advice. Open the ALB and AXGN stock pages for the full models.
Not investment advice.